0001209191-20-002057.txt : 20200106 0001209191-20-002057.hdr.sgml : 20200106 20200106175243 ACCESSION NUMBER: 0001209191-20-002057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200102 FILED AS OF DATE: 20200106 DATE AS OF CHANGE: 20200106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DRISCOLL FREDERICK W CENTRAL INDEX KEY: 0001129890 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38327 FILM NUMBER: 20511192 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cue Biopharma, Inc. CENTRAL INDEX KEY: 0001645460 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473324577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-949-2680 MAIL ADDRESS: STREET 1: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Imagen Biopharma, Inc. DATE OF NAME CHANGE: 20150617 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-02 0 0001645460 Cue Biopharma, Inc. CUE 0001129890 DRISCOLL FREDERICK W 21 ERIE STREET CAMBRIDGE MA 02139 1 0 0 0 Stock Option (right to buy) 16.31 2020-01-02 4 A 0 8000 0.00 A 2021-01-02 2030-01-02 Common Stock 8000 8000 D Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Director Compensation Policy. /s/ Frederick Driscoll by Mark Busch, attorney-in-fact 2020-01-06